Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Having read a bit more a big question is whether increasing the MTD will in fact increase p21 levels. The company clearly sees this as a measure of success, and the initial info- 50% of patients with a 10% increase-is not great.

Knowing the next set of numbers is critical- if the trend is for increasing p21 with increasing MTD, as expected, calling it good news would be an understatement.

Look: coming across a stock OTC that might have a startling new drug for many types of cancer AND a number of revolutionary antibiotics, it seems too good to be true, really. And yet the more I read CTIX appears to be the real deal. Time will tell.

Sam.